| Literature DB >> 30828355 |
Matthias Möhner1, Yimeng Liu2, Gary M Marsh2.
Abstract
BACKGROUND: Indications were found that a diagnostic bias could have contributed to the National Cancer Institute's (NCI) suggestion of a persistent increased mortality risk for nasopharyngeal cancer (NPC).Entities:
Keywords: Cohort mortality study; Formaldehyde; Nasopharyngeal cancer; National Cancer Institute; Occupational health; Re-analyses
Year: 2019 PMID: 30828355 PMCID: PMC6383225 DOI: 10.1186/s12995-019-0224-2
Source DB: PubMed Journal: J Occup Med Toxicol ISSN: 1745-6673 Impact factor: 2.646
Distribution of pharyngeal cancer cases in the NCI-cohort by sub-localization and period of follow-up
| ICD8 | 1934–1979 | 1980–2004 | 1934–2004 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Obs | Exp | SMR (95%CI) | Obs | Exp | SMR (95%CI) | Obs | Exp | SMR (95%CI) | |
| 146 (Oropharynx) | 5 | 2.96 | 1.69 (0.55–3.95) | 8 | 8.74 | 0.92 (0.40–1.80) | 13 | 11.70 | 1.11 (0.59–1.90) |
| 147 (Nasopharynx) | 7 | 2.17 | 3.23 (1.30–6.65) | 4 | 3.61 | 1.11 (0.30–2.84) | 11 | 5.78 | 1.90 (0.95–3.40) |
| 148 (Hypopharynx) | 2 | 1.85 | 1.08 (0.13–3.91) | 3 | 4.57 | 0.66 (0.14–1.92) | 5 | 6.42 | 0.78 (0.25–1.82) |
| 149 (Pharynx, unspecified) | 1 | 4.37 | 0.23 (0.01–1.28) | 20 | 13.19 | 1.52 (0.93–2.34) | 21 | 17.56 | 1.20 (0.74–1.83) |
| 146–9 (Pharynx) | 15 | 11.34 | 1.32 (0.74–2.18) | 35 | 30.12 | 1.16 (0.81–1.62) | 50 | 41.46 | 1.21 (0.90–1.59) |
Distribution of pharyngeal cancer cases in the NCI-cohort by sub-localization and study site (1934–2004)
| ICD8 | Study site | Obs | Exp | SMR | 95% CI |
|---|---|---|---|---|---|
| 147 (NPC) | Wallingford | 6 | 1.08 | 5.57 | 2.04–12.1 |
| 146,148,149 | Wallingford | 11 | 6.58 | 1.67 | 0.83–2.99 |
| 146–149 | Wallingford | 17 | 7.66 | 2.22 | 1.29–3.55 |
| 147 (NPC) | All other plants | 5 | 4.70 | 1.06 | 0.35–2.48 |
| 146,148,149 | All other plants | 28 | 29.09 | 0.96 | 0.64–1.39 |
| 146–149 | All other plants | 33 | 33.79 | 0.98 | 0.67–1.37 |
| 147 (NPC) | Total | 11 | 5.78 | 1.90 | 0.95–3.40 |
| 146,148,149 | Total | 39 | 35.67 | 1.09 | 0.78–1.49 |
| 146–149 | Total | 50 | 41.46 | 1.21 | 0.90–1.59 |
Distribution of pharyngeal cancer cases in the NCI-cohort by cumulative exposure to formaldehyde and period of follow-up
| Exposure (ppm-yr) | 1934–1979 | 1980–2004 | 1934–2004 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Obs | Exp | SMR (95%CI) | Obs | Exp | SMR (95%CI) | Obs | Exp | SMR (95%CI) | |
| 0 | 2 | 1.06 | 1.89 (0.23–6.83) | 3 | 2.43 | 1.24 (0.25–3.61) | 5 | 3.49 | 1.43 (0.47–3.35) |
| (0, 0.5] | 8 | 3.59 | 2.23 (0.96–4.39) | 15 | 12.25 | 1.22 (0.69–2.02) | 23 | 15.84 | 1.45 (0.92–2.18) |
| (0.5, 5.5] | 3 | 4.13 | 0.73 (0.15–2.12) | 9 | 9.94 | 0.90 (0.41–1.72) | 12 | 14.07 | 0.85 (0.44–1.49) |
| > 5.5 | 2 | 2.56 | 0.78 (0.09–2.82) | 8 | 5.50 | 1.46 (0.63–2.87) | 10 | 8.06 | 1.24 (0.59–2.28) |
| Total | 15 | 11.34 | 1.32 (0.74–2.18) | 35 | 30.12 | 1.16 (0.81–1.62) | 50 | 41.46 | 1.21 (0.90–1.59) |
Distribution of pharyngeal cancer cases in the NCI-cohort by cumulative exposure to formaldehyde and study site (1934–2004)
| Exposure (ppm-yr) | Plant 1 (Wallingford) | Plant 2–10 (all other plants) | ||||
|---|---|---|---|---|---|---|
| Obs | Exp | SMR (95%CI) | Obs | Exp | SMR (95%CI) | |
| 0 | 0 | 0.77 | 0.00 (0.00–4.82) | 5 | 2.72 | 1.84 (0.60–4.29) |
| (0, 0.5] | 6 | 2.21 | 2.71 (1.00–5.90) | 17 | 13.63 | 1.25 (0.73–2.00) |
| (0.5, 5.5] | 6 | 2.85 | 2.10 (0.77–4.57) | 6 | 11.21 | 0.54 (0.20–1.17) |
| > 5.5 | 5 | 1.83 | 2.73 (0.89–6.38) | 5 | 6.23 | 0.80 (0.26–1.87) |
| Total | 17 | 7.66 | 2.22 (1.29–3.55) | 33 | 33.79 | 0.98 (0.67–1.37) |